- TotalEnergies and Deutsche ReGas are in talks for an LNG import agreement in Germany.
- Airbus is in talks to sell about 12 additional A220 airliners to Delta Air Lines.
- JPMorgan’s profit fell in Q2, hit by higher provisions to cover potential losses, amid quantitative tightening.
- Morgan Stanley also posted a drop in quarterly profits.
- Taiwan Semiconductor Manufacturing reports a 76.3% increase in second quarter net income.
- Netflix selects Microsoft to manage advertising on its platform.
- Hugo Boss raises its annual earnings guidance.
- Kone Oyj cuts its outlook for 2022.
- Ericsson reports operating profit of SEK 7.3 billion in the second quarter.
- The Swatch Group reports an 18.5% increase in net profit to 320 million Swiss francs.
- Partners Group buys 19 logistics assets in Finland.
- Panasonic wants to invest $4 billion in a battery factory in the US.
- Bayer sells its testosterone treatment Nebido to the pharmaceutical company Gruenenthal.
- Deutsche Telekom is to sell 51% stake in its antenna subsidiary to Brookfield and DigitalBridge.
- American Airlines receives approval from the U.S. Department of Transportation to serve Cuban airports.
- Umicore plans to build an active cathode battery materials plant in Canada.
- Intel said Thursday that it has begun notifying customers that it plans to raise prices on most of its products because of rising costs.
- Twitter said it was not planning any company-wide layoffs but would likely continue to restructure its operations.
- Conocophillips announced that it will take a 30% stake in Sempra Energy's liquefied natural gas (LNG) plant in Port Arthur, Texas, as the U.S. oil and gas producer expands its LNG business to meet strong demand.
- Occidental Petroleum - Berkshire Hathaway, led by Warren Buffett, said it bought an additional 4.3 million shares of the oil company this week, raising its stake to 19.2%.
- Amazon - The online shopping giant offered to refrain from using seller data for its own retail operations and made other concessions in a bid to close an antitrust investigation, EU regulators said.
- Regeneron Pharmaceuticals - The pharmaceutical company announced that the Phase III trial of Dupixent (Dupilumab) showed positive results in children aged 1 to 11 with eosinophilic esophagitis.
- Alphabet- The Italian competition authority (AGCM) said Thursday it had opened an investigation targeting Google for alleged abuse of a dominant position in data portability, a charge the group denied.
Main earnings reports of the day: Taiwan Semiconductor, JPMorgan, Morgan Stanley, Barrick Gold Corporation ... All the agenda here.